President's Dream Colloquium on Understanding Medical Marijuana

Secrets of the Cannabis Genome

Watch the Recorded Web Stream

Recorded on February 9, 2017

Lecture Topics

Current President Dream's Colloquium

One Health: Connections and Collaborations

Learn about the Public Lectures starting January 25

Learn more

About the Speaker

Dr. Jonathan Page
Founder and CEO, Anandia Labs, Adjunct Professor, Botany Department, UBC

Jonathan is the co-founder of Anandia Labs, a cannabis biotechnology startup based in Vancouver, and an Adjunct Professor in the Botany Department at the University of British Columbia. He has spent his scientific career deciphering the genetic and biochemical secrets of medicinal plants, including the production of THC and other cannabinoids in cannabis. He received his BSc (1991) and PhD (1998) both from the University of British Columbia, undertook training as an NSERC Postdoctoral Fellow at the University of Munich (1998-99) and was a Group Leader at the Leibniz Institute of Plant Biochemistry in Halle, Germany (1999-2003). In 2003, he returned to Canada to work as a Senior Research Officer at the National Research Council’s Plant Biotechnology Institute (2003-2013). Jonathan co-led the Canadian team that reported the first sequence of the cannabis genome and his work has helped elucidate the biochemical pathway leading to the major cannabinoids. His papers have appeared in PNAS, The Plant Cell and Genome Biology. He serves on the Board of Directors for the Canadian Consortium for Investigation of Cannabinoids, and takes an active role in discussions of cannabis policy and regulations. Jonathan continues to work both on building a strong basic research foundation for cannabis and turning Anandia Labs into a world leader in cannabis genetics and biotech.

Publications